Department of Surgery (A), Heinrich-Heine-University and University Hospital Duesseldorf, Duesseldorf, Germany.
Int J Colorectal Dis. 2022 Aug;37(8):1909-1917. doi: 10.1007/s00384-022-04226-3. Epub 2022 Aug 2.
The question of whether immunosuppressed (IS) patients should be offered elective sigmoidectomy following a single episode of diverticulitis is controversial. We intended to examine the perioperative outcome of IS and immunocompetent (IC) patients after sigmoid resection.
A single institutional cohort study was conducted, including all surgically treated patients with sigmoid diverticulitis between 2004 and 2021. IS and IC patients were further subdivided into emergency and elective cases. Morbidity and mortality in both groups and factors influencing surgical outcome were examined using uni- and multivariate regression analyses.
A total of 281 patients were included in the final analysis. Emergency surgery was performed on 98 patients while 183 patients underwent elective sigmoid resection. Emergency sigmoidectomy demonstrates significantly higher morbidity and mortality rates in IS patients as compared to IC patients (81.81% vs. 42.1%; p = 0.001, respectively 27.27% vs. 3.94%; p = 0.004), while major morbidity and mortality was similar in both groups in the elective setting (IS: 23.52% vs. IC: 13.85%; p = 0.488, respectively IS: 5.88% vs. IC: 0%; p = 1). On multivariate regression analysis for major postoperative morbidity, ASA score [OR 1.837; (95% CI 1.166-2.894); p = 0.009] and emergency surgery under immunosuppression [OR 3.065; (95% CI 1.128-8.326); p = 0.028] were significant. In-hospital mortality was significantly related to age [OR 1.139; (95% CI 1.012-1.282); p = 0.031], preoperative CRP count [OR 1.137; (95% CI 1.028-1.259); p = 0.013], and immunosuppression [OR 35.246; (95% CI 1.923-646.176), p = 0.016] on multivariate analysis.
Elective surgery for sigmoid diverticulitis in immunocompromised patients demonstrates higher efficacy and safety when compared to sigmoid resection in the emergency setting.
免疫抑制(IS)患者在单次发作憩室炎后是否应接受选择性乙状结肠切除术,这是一个存在争议的问题。我们旨在研究 IS 和免疫功能正常(IC)患者乙状结肠切除术后的围手术期结果。
进行了一项单机构队列研究,纳入了 2004 年至 2021 年间所有接受乙状结肠憩室炎手术治疗的患者。IS 和 IC 患者进一步分为急诊和择期病例。使用单因素和多因素回归分析检查两组患者的发病率和死亡率以及影响手术结果的因素。
共有 281 名患者纳入最终分析。98 名患者接受了急诊手术,183 名患者接受了择期乙状结肠切除术。与 IC 患者相比,IS 患者的急诊乙状结肠切除术发病率和死亡率显著更高(分别为 81.81%比 42.1%;p=0.001 和 27.27%比 3.94%;p=0.004),而在择期手术中,两组的主要发病率和死亡率相似(IS:23.52%比 IC:13.85%;p=0.488,分别为 IS:5.88%比 IC:0%;p=1)。多因素回归分析显示,术后主要并发症与美国麻醉医师协会(ASA)评分[比值比(OR)1.837;(95%置信区间 1.166-2.894);p=0.009]和免疫抑制下的急诊手术[OR 3.065;(95%置信区间 1.128-8.326);p=0.028]显著相关。住院死亡率与年龄[OR 1.139;(95%置信区间 1.012-1.282);p=0.031]、术前 C 反应蛋白(CRP)计数[OR 1.137;(95%置信区间 1.028-1.259);p=0.013]和免疫抑制[OR 35.246;(95%置信区间 1.923-646.176);p=0.016]显著相关。
与急诊乙状结肠切除术相比,免疫功能低下患者的择期乙状结肠切除术在疗效和安全性方面更高。